US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

25.14

+0.37181.50%

Volume:8K

Turnover:188.79K

Market Cap:58.32M

PE:- -

High:25.14

Open:24.74

Low:24.74

Close:24.77

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:5.82

T/O Rate:0.32%

Dividend:1.70

Dividend Rate:6.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301

InFocus Group Raises $465,000 to Back New Products and Gaming Tech

Strata Mental Health Solutions awarded training grant by Compass Pathways

Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each

MT Newswires Live

Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi

NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System

MT Newswires Live

Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares

GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference

Evion Moves to Cancel Unpaid Placement Shares and Options

Vanadium Resources Plans Major Share and Option Placement on ASX

Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy

Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program

THOMSON REUTERS

Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training

THOMSON REUTERS

Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14

Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year

THOMSON REUTERS

Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/PSIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":25.14,"timestamp":1789393283773,"preClose":24.7682,"halted":0,"volume":7528,"delay":0,"changeRate":0.015011183695222113,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Trading","change":0.3718,"latestTime":"09-14 09:41:29 EDT","open":24.7417,"high":25.14,"low":24.7417,"amount":188792.60416000002,"amplitude":0.016081,"askPrice":25.42,"askSize":100,"bidPrice":25.08,"bidSize":180,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":24.7682,"sharesOutstanding":1184976,"nav":24.85,"aum":57650992.8,"dividendRate":0.067812,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.15,"preClose":24.7682,"latestTime":"08:50 EDT","volume":963,"amount":24219.650304,"timestamp":1789390215802,"change":0.3818,"changeRate":0.015415,"amplitude":0.002019},"postHourTrading":{"tag":"盘后","latestPrice":24.82,"preClose":24.7682,"latestTime":"19:30 EDT","volume":41,"amount":1012.1888,"timestamp":1789169404986,"change":0.0518,"changeRate":0.002091,"amplitude":0},"volumeRatio":5.822244,"impliedVol":0.3137,"impliedVolPercentile":0.4303},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.822244,"shares":2319976,"dividePrice":1.7048,"high":25.14,"amplitude":0.016081,"preClose":24.7682,"low":24.7417,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":25.14,"committee":0.285714,"eps":0,"divideRate":0.067812,"volume":7528,"delay":0,"ttmEps":0,"open":24.7417,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.86,"twentyDayClose":25.2736,"sixtyDayClose":19.8284},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667668873","title":"NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668873?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:04","pubTimestamp":1789383892,"startTime":"0","endTime":"0","summary":"NRx Pharma unit GeNeuro wins European patent for ALS antibody candidate GNK-301NRx Pharmaceuticals’ GeNeuro unit won a European patent covering GNK-301, a monoclonal antibody targeting HERV-K envelope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL34d93C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014021.USD","SG9999014039.USD","NDAQ","GNK","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BCDF","LU2210149790.SGD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4007","BK4588","BK4585","NRXP","BK4112","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00BQXX3F31.USD","PSIL","IE00BQXX3D17.EUR","LU0314104364.USD","LU2095319765.USD","BK4021","SG9999014013.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655067","title":"InFocus Group Raises $465,000 to Back New Products and Gaming Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655067?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:37","pubTimestamp":1789371472,"startTime":"0","endTime":"0","summary":"The latest update is out from Frugl Group Limited ( ($AU:IFG) ). InFocus Group Holdings Limited has completed a capital raising of $465,000, includ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257102","title":"Strata Mental Health Solutions awarded training grant by Compass Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257102?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"Strata Mental Health Solutions announced it has been awarded one of the five U.S. HCP training grants awarded by Compass Pathways (CMPS) to develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311579","title":"Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311579","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311579?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:30","pubTimestamp":1789151447,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  shares were up nearly 11% in afternoon trading on Friday after the company's Chief Executive Officer Sergio Traversa and Chief Financial Officer Maged Shenouda bought 200,000 shares each, according to separate regulatory filings.Trading volume stood at over 1.7 million shares against a daily average of about 1.8 million.Price: 4.52, Change: +0.44, Percent Change: +10.93","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PSIL","BK4539","LENZ","RLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057576","title":"Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144227,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The STYLE 1 study is a Phase 3 trial run by...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","SNYNF","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666892521","title":"NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System","url":"https://stock-news.laohu8.com/highlight/detail?id=2666892521","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666892521?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:32","pubTimestamp":1789126372,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals'  HOPE Therapeutics unit will deploy Zeta Surgical's TMS Robotic System in Florida, with its clinical staff already undergoing orientation and training, NRx said Friday.TMS is a non-invasive therapy mainly used for treatment-resistant depression, and the robotic system's deployment will support NRx's phase 2/3 trial of an NRX-101 combination therapy, the company said.Financial details of the deployment were not disclosed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4007","NRXP","PSIL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529085","title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529085","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529085?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:30","pubTimestamp":1789126244,"startTime":"0","endTime":"0","summary":"Relmada CFO Maged Shenouda acquires $843,140 of common sharesRelmada Therapeutics CFO Maged Shenouda bought 200,000 common shares in open-market purchases at about $4.20–$4.25 each.His directly held s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL4WN5mf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666293255","title":"GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666293255","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666293255?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:01","pubTimestamp":1789124491,"startTime":"0","endTime":"0","summary":"GH Research to hold one-on-one investor meetings at Morgan Stanley Global Healthcare ConferenceGH Research will hold one-on-one investor meetings at the Morgan Stanley 24th Annual Global Healthcare Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9pJPZ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0795875086.SGD","LU1363072403.SGD","LU1548497426.USD","LU0971096721.USD","LU1064131342.USD","LU2028103732.USD","KBWB","LU0557290698.USD","BK4504","LU2347655156.SGD","BK4127","IE00B3S45H60.SGD","LU1720051108.HKD","LU1244550494.USD","LU0528227936.USD","PSIL","BK4585","LU1074936037.SGD","LU1732799900.SGD","IE00BKVL7J92.USD","LU0234570918.USD","LU0314104364.USD","GHRS","LU1244550221.USD","LU0225283273.USD","LU1989772923.USD","LU0390134368.USD","LU0267386448.USD","LU0882574139.USD","IE00BZ1G4Q59.USD","LU2023251221.USD","BK4534","LU2271345857.HKD","LU2357305700.SGD","BK4007","LU1244550577.SGD","BK4516","LU1791710400.SGD","LU2264538146.SGD","LU2089283258.USD","IE00B775SV38.USD","LU1732800096.USD","LU0106831901.USD","LU1989772840.SGD","LU0158827781.USD","LU0320765646.SGD","IAI","LU0098860793.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666548670","title":"Evion Moves to Cancel Unpaid Placement Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666548670","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666548670?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:22","pubTimestamp":1789096958,"startTime":"0","endTime":"0","summary":"BlackEarth Minerals NL ( ($AU:EVG) ) has shared an update. Evion Group NL has moved to unwind part of a recent capital raising after certain partic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","EVG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666514254","title":"Vanadium Resources Plans Major Share and Option Placement on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666514254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666514254?lang=en_us&edition=fundamental","pubTime":"2026-09-11 08:37","pubTimestamp":1789087034,"startTime":"0","endTime":"0","summary":"Vanadium Resources Ltd. ( ($AU:VR8) ) has provided an announcement. Vanadium Resources Ltd. has announced a proposed capital raising through the is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanadium-resources-plans-major-share-and-option-placement-on-asx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanadium-resources-plans-major-share-and-option-placement-on-asx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659418","title":"Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659418?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:50","pubTimestamp":1789051821,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study initiation plans, a Breakth...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910405","title":"Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910405?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:25","pubTimestamp":1789050337,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announces plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with maj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","BK4007","BBC","NVIB","PSIL","IDNA","BK4139","ABVC","MEDX","OPTH","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567022","title":"Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567022?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8WKBZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","PSIL","BK4139","MEDX","ALKS","IBRN","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956780","title":"Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666956780?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:35","pubTimestamp":1789036500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8YJNLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562043","title":"Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562043?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:30","pubTimestamp":1789036255,"startTime":"0","endTime":"0","summary":"Compass Pathways management attends investor conference fireside chats in New York week of Sept. 14Compass Pathways management to join investor conferences in New York during the week of Sept. 14.Fire","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL86MRVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554185","title":"Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554185?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:05","pubTimestamp":1788998708,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) “presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera. The dat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL","BK4139","LU0053671581.USD","IRON","DISC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535291","title":"U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535291","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535291?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:24","pubTimestamp":1788960267,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-UGI, Chewy, Cognyte SoftwareSeptember 9 (Reuters)-The main U.S. stock indexes were on course to open lower on Wednesday, when oil prices surged past the market-sensitive $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4510Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJTD4V19.USD","LU2168564065.EUR","LU0077335932.USD","OILT","FMED","IE00B19Z3581.USD","LU2065170008.USD","SGXZ81514606.USD","BK4507","LU0788109477.HKD","BK4550","BK4543","LU0345780950.USD","LU1316542783.SGD","LU2347655156.SGD","CMPS","LU2471134879.HKD","BK4534","LU0198837287.USD","LU2250418816.HKD","BK4539","IYE","LU0985320562.USD","DRLL","IE00BSNM7G36.USD","IE00BQXX3D17.EUR","IE00B7SZLL34.SGD","IE000M9KFDE8.USD","LU1564329628.SGD","IE000MB6IJN5.SGD","LU2125154778.USD","FBYY","IE00BJLML261.HKD","BK4570","IE00BJTD4N35.SGD","LU0354030438.USD","LU0957808578.USD","LU2462591277.SGD","LU2750360997.AUD","LU2896262040.SGD","BK4112","LU0130518102.USD","XLC","IE00B19Z8W00.USD","LU0738911758.USD","DIG","LU0096364046.USD","LU2471134796.USD","LU1551013425.SGD","LU2357627491.SGD","LU0097036916.USD","LU0784385840.USD","BK4200","LU2552382132.HKD","LU0985489474.SGD","LU1261432733.SGD","LU0320765059.SGD","LU1642822529.SGD","LU0949170772.SGD","LU2473716301.USD","IE00BFMHRM44.USD","LU1791710582.SGD","LU0096362180.USD","LU0784385170.HKD","LU0289739699.SGD","LU0265550946.USD","LU1883866441.USD","LU2458330243.SGD","LU0149725797.USD","LU1551013342.USD","LU0011850046.USD","LU1697837992.HKD","LU1582987597.SGD","BK4196","LU0823434740.USD","LU0070217475.USD","LU2552382215.SGD","LU0068578508.USD","LU0256863811.USD","LU1429558221.USD","GB00BDT5M118.USD","BK4535","BK4201","LU0348723411.USD","LFST","LU0211328371.USD","LU2420271590.USD","LU0642271901.SGD","LU1917777945.USD","LU0648001328.SGD","FXG","IE00BJJMRX11.SGD","LU0859254822.USD","LU2471134952.CNY","LU0128525929.USD","SG9999014898.SGD","BK4600","LU1894683264.USD","LU0788109394.HKD","LU0080751232.USD","BK4566","LU0256863902.USD","LU0868494617.USD","LU0792757196.USD","LU1861217088.USD","IE00B19Z9505.USD","LU2764262908.HKD","LU0300736062.USD","IE0003U64NQ7.SGD","IE00BFSS7M15.SGD","LU0823411888.USD","LU2087625088.SGD","FTXN","LU0784384876.USD","IE00B19Z8X17.USD","LU0957791311.USD","BK4581","LU2361044865.SGD","SG9999014914.USD","LU2129689605.HKD","AWAY","IE00B1BXHZ80.USD","LU2023250843.SGD","LU0552385451.USD","LU2097829019.USD","LU0912757837.SGD","IE00B5TLWC47.USD","BKNU","CVX","EVMN","LU0345774391.USD","IE000WAW04H5.SGD","BK4547","BK4139","LU2168564222.USD","IE00BK4W5L77.USD","LU2102340556.USD","LU1839511570.USD","LU1868836914.USD","LU1989764664.SGD","LU0433182093.SGD","LU1116320737.USD","IE000KEQY171.SGD","LU1852331112.SGD","LU0210533765.USD","LU0724617625.USD","LU0477156953.USD","LU2213496289.HKD","METU","LU0098860793.USD","LU2168563687.JPY","BK4548","LU2471134523.USD","LU1992135399.USD","IE00BQXX3C00.GBP","LU2236285917.USD","LU2326559502.SGD","LU1582987324.SGD","LU1670711123.USD","METW","LU2602419157.SGD","LU0889565833.HKD","LU0130103400.USD","LU1979441026.SGD","LU0276348264.USD","LU1894683348.USD","IXC","LU0690374961.EUR","LU0345770308.USD","IE00BMPRXN33.USD","HK0000914686.HKD","LU1868837300.USD","LU0203202063.USD","IE00BMPRXR70.SGD","LU1988902786.USD","ASO","LU1992135472.HKD","IE00B2Q91V27.USD","IE00BKDWB100.SGD","LU0980610538.SGD","LU2417539215.USD","IE00BFXG1179.USD","LU0820562030.AUD","LU0708995401.HKD","LU2063271972.USD","LU1232071149.USD","SGXZ99366536.SGD","LU0323591593.USD","SUNB","LU0109392836.USD","LU0006306889.USD","IE0034235188.USD","LU1674673428.USD","LU1868836757.USD","LU1670627923.USD","BK4595","COP","TEXU","BK4094","LU0072461881.USD","LU1084165304.USD","LU2456880835.USD","LU1201861165.SGD","IE000W1ABFV2.USD","LU1003077747.HKD","SG9999015945.SGD","LU1066051498.USD","LU1119994496.HKD","LU2065171402.SGD","LU1974910355.USD","BK4583","IE00B4JS1V06.HKD","SG9999002232.USD","LU1564329115.USD","LU1815333072.USD","LU1815336760.USD","SG9999014559.SGD","LU2265009873.SGD","WNDR","LU2272731782.SGD","LU0672654240.SGD","LU1121112475.USD","LU0820561818.USD","LU2488822045.USD","IE0009G5SDU7.USD","FBX","LU0708994859.HKD","IE00B19Z3B42.SGD","LU1564329032.USD","BK4077","LU0353189763.USD","LU2168564149.EUR","BK4140","LU2505996509.AUD","LU0211326755.USD","LU1435385759.SGD","IE00B7KXQ091.USD","LU2054465674.USD","LU0061474960.USD","LU1935043536.SGD","VDE","LU0211327993.USD","BK4122","GB00B4LPDJ14.GBP","BKNG","LU1823568750.SGD","IE00BFSS8Q28.SGD","BK4023","LU1046421795.USD","LU0203345920.USD","IE00BZ1G4Q59.USD","LU0648000940.SGD","LU1868836591.USD","IE0001KFT4U8.USD","SG9999015952.SGD","OXY","LU0683600562.USD","LU1720051017.SGD","SG9999014906.USD","LU1066053197.SGD","IE00B3SWFQ91.USD","TYRA","IE0002270589.USD","LU1496350171.SGD","LU2764263039.SGD","LU1582986359.USD","METV","LU0310800379.SGD","BK4585","LU0058720904.USD","LU2237957902.USD","LU1074936037.SGD","LU2458330169.SGD","LU1267930490.SGD","LU1674673691.USD","LU2463028550.USD","SOCL","LU1496350502.SGD","SG9999014567.USD","SMMT","LU0654597011.USD","LU0823421416.USD","LU2360032135.SGD","LU2361044949.HKD","IE000SO60NU8.SGD","LU2860962120.EUR","PAWZ","LU0820561909.HKD","LU2237957811.SGD","LU1242518857.USD","LU0426417589.USD","LU1032466523.USD","LU0719512351.SGD","LU0106261372.USD","IE00BKVL7J92.USD","IE00BMPRXQ63.HKD","LU2272731600.USD","LU1548497426.USD","LU1720051108.HKD","LU0157215616.USD","LU1935042215.USD","BK4197","LU2498475776.HKD","LU0882574139.USD","LU1929549753.HKD","LU1169590202.USD","LU2552382058.USD","LU2764263203.CNY","IE000YTNTUN2.SGD","IE0005OL40V9.USD","SG9999002521.SGD","LU2168564495.EUR","IE00B4YYXB79.USD","LU0476273544.USD","UGI","IE0009356076.USD","LU0238689110.USD","FBL","BK4561","INGM","SGXZ23171101.USD","LTL","LU2750360641.GBP","LU2360107671.USD","LU2361045086.USD","LU0368265418.SGD","LU0868494708.USD","CHWY","LU0203201768.USD","BK4516","LU2381873111.SGD","LU0466842654.USD","LU2023250504.SGD","LU0130517989.USD","LU1791710400.SGD","RSPC","LU0128525689.USD","LU0786609619.USD","LU0130102774.USD","LU0265550359.USD","HK0000914660.USD","LU0300736492.USD","LU1699723380.USD","METG","BK4559","LU0942090050.USD","LU0215105999.USD","LU0210528500.USD","XOMO","BK4215","SG9999001077.SGD","FENY","IGE","LU0234572021.USD","SMETAmain","LU2756315664.SGD","LU0143551892.USD","LU1778281490.HKD","BK4587","LU1145028129.USD","LU0316494557.USD","LU0122376428.USD","LU2129689514.USD","LU1861220207.SGD","LU2129689431.USD","LU2746668974.SGD","LU0320765646.SGD","IE00BJJMRY28.SGD","LU1127390331.HKD","XOMZ","LU1069347547.HKD","LU1069344957.HKD","LU1235294995.USD","LU1564329461.SGD","LU1582986433.USD","LU0267386448.USD","PSIL","LU1861558580.USD","LU0345770993.USD","BK4227","DOW","LU1267930573.SGD","BK4104","LU0964807845.USD","LU1035773651.USD","FCG","LU0661504455.SGD","LU0477156797.USD","LU2360106780.USD","XDAT","LU0353189680.USD","LU0314106906.USD","LU1670710588.SGD","LU1153585028.USD","LU1489326972.SGD","CHYM","IE00B1XK9C88.USD","LU1043141396.HKD","SG9999002224.SGD","LU1941712348.USD","LU0878866978.SGD","LU1732799900.SGD","GB00B4QBRK32.GBP","LU0072462426.USD","LU2317271919.USD","XOM","LU0456854461.SGD","LU0345781412.USD","BK4142","LU2404859741.USD","OGIG","LU0787776722.HKD","LU0211331839.USD","TH","LU0225283273.USD","FBY","LU0444971666.USD","LU0056508442.USD","LU0417517546.SGD","LU2264538146.SGD","LU1267930227.SGD","LU0310800965.SGD","SGXZ80539844.SGD","HK0000304797.USD","LU0170899867.USD","LU0345769128.USD","LU0266512127.USD","LU2999663052.SGD","SG9999015986.USD","METQ","LU0174119429.USD","LU0976567544.SGD","LU1935043023.USD","IE00BK4W5M84.HKD","LU1585245621.USD","LU0061475181.USD","IE0000B7K699.USD","LU1366333091.USD","GXPE","LU0234570918.USD","LU1941712264.USD","LU2462591350.SGD","LU1935043452.HKD","VTRS","WLK","LU0278409577.USD","LU1814569148.SGD","SG9999014880.SGD","LU1150488135.SGD","LU2272731865.HKD","XLE","LU2242650005.HKD","IEO","LU0557290698.USD","LU2237438978.USD","BK4090","LU1242518931.SGD","LU2746668461.USD","SIG","LU0052756011.USD","LU1280957306.USD","LU1430594728.SGD","LU1935042488.USD","IE00BWXC8680.SGD","LU1506573853.SGD","LU2462157665.USD","LU1035775433.USD","LU0029864427.USD","LU0266512473.USD","LU2322448957.HKD","LU2592432038.USD","BKKT","LU1162221912.USD","SG9999018865.SGD","IE00BGHQF524.EUR","SG9999018857.SGD","CGNT","SGXZ31699556.SGD","LU1201861249.SGD","LU2322448791.USD","LU0689472784.USD","LU2133065610.SGD","LU0310799852.SGD","LU0496365809.HKD","LU2023250330.USD","IE0004445239.USD","LU0054578231.USD","BK4524","CI","IE00B3CCJ963.GBP","LU1670628061.USD","TRUN","WEEI","LU2430703095.HKD","BK4212","SG9999004303.SGD","LU2461242641.AUD","LU2462611646.USD","IE00B775H168.HKD","LU0553294199.USD","IE000BZT7R73.USD","LU0889566641.SGD","LU0053666078.USD","LU1914381329.SGD","LU1868837136.USD","LU1366192091.USD","LU0079474960.USD","META","HK0000304805.HKD","LU2347655073.USD","LU1629891620.HKD","SG9999015978.USD","LU0545039389.USD","LU0949170426.SGD","LU2403377893.USD","IE000ITXATA3.USD","LU0726765562.USD","LU0082616367.USD","LU1059921491.USD","LU1861559042.SGD","BK4007","LU2543165471.USD","TRUC","LU0070302665.USD","XOMX","LU1267930813.SGD","LU1732800096.USD","JILL","TTAN","LU1267930730.SGD","SG9999001440.SGD","LU2247934214.USD","LU0612318385.USD","LU0345774631.USD","LU0308772762.SGD","LU1803068979.SGD","LU0795875086.SGD","BK4588","LU2505996681.GBP","LU0994945656.USD","LU0943347566.SGD","LU2244417387.USD","SG9999014575.USD","IE000F7OJYX1.SGD","LU0203347892.USD","LU0823421333.USD","IRT","VOX","BK4213","LU1670711040.USD","IE00BN29S564.USD","LU0345769631.USD","IE0034235303.USD","LU2756315318.SGD","LU2125154935.USD","LU0187121727.USD","LU0061474705.USD","LU0256331488.USD","LU0211326839.USD","SG9999015358.SGD","LU0444973449.USD","GAMR","LU1670710661.SGD","LU1301847155.USD","LU1718418525.SGD","LU2087621335.USD","LU0314104364.USD","LU0690374615.EUR","LU0612318971.USD","LU2065171311.SGD","LU0154236417.USD","LU2487616109.SGD","LU2954938101.SGD","IE00B5949003.HKD","METD","SG9999014542.SGD","LU2404859667.USD","FCOM","LU1043141123.HKD","LU2106854487.HKD","LU1935042991.SGD","LU1169589451.USD","LU0640476718.USD","IE0004445015.USD","LU0784383803.USD","LU0208291251.USD","LU0528227936.USD","LU0127658192.USD","LU1150488218.USD","LU2430703178.SGD","LU0979878070.USD","LU2430703251.USD","LU1430597077.USD","LU0795875169.SGD","LU0266013472.USD","LU0210536198.USD","LU0823434583.USD","SG9999015341.SGD","LU2720916845.USD","BPAY","BK4592","LU1804176565.USD","LU0133085943.USD","SFD","LU0320765489.SGD","LU2357305700.SGD","LU0426412945.USD","LU1064131342.USD","ERX","SG9999017495.SGD","GXPC","SGXZ51526630.SGD","IE00BQXX3F31.USD","LU2065169927.USD","LU1116320901.HKD","LU1571399168.USD","LU0162691827.USD","LU0354030511.USD","LU0109391861.USD","LU0630314457.HKD","NULC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580430","title":"Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580430","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580430?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:46","pubTimestamp":1788954365,"startTime":"0","endTime":"0","summary":"BUZZ-Compass Pathways rises after one-year data for psychedelic-based depression drug** Shares of Compass PathwaysCMPS.Orise 5.3% to $14.78 premarket** Co reports 52-week data from its late-stage trial showing that additional doses of its psychedelic-based treatment, COMP360, helped sustain reductions in depression symptoms in patients with treatment-resistant depression ** CMPS says patients who were initially assigned to the 25 mg COMP360 arm and received an additional dose in the open-label portion of the study showed an average 13-point reduction from baseline on a scale used to measure the severity of depressive episodes at week 52** Across all participants receiving a 25 mg dose during the open-label phase, response rates were 40%-45% and about 30% achieved remission during the six weeks after treatment** Compass says a rolling submission of its U.S. new drug application is underway, with final filing expected in Q4** It expects a potential commercial launch in H1 2027** As of la","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4N4510ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584065","title":"Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584065?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584051","title":"Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584051?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA4GLXR1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}